From a press release:
VIVUS, Inc. ... which recently began selling the obesity drug Qsymia
(phentermine and topiramate extended-release) capsules CIV in the United
States, today announced that its Board of Directors has appointed
Michael Astrue to serve as its Chairman and Anthony Zook to serve as its
Chief Executive Officer ...
Mr. Astrue said, "We intend to move quickly on our four
Wednesday, 24 July 2013
New Job For Astrue
Posted on 11:17 by Unknown
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment